Dec 22, 2020

COVID-19
We have to protect the old people first to prevent the most COVID-19 deaths. COVID-19 is most deadly to older people, so vaccinating the roughly 7-10% of people who are over 70 would prevent over 75% of COVID deaths. These …
The UK has already approved the Pfizer COVID vaccine. This is ahead of the EU and the USA. Everyone knows the Pfizer COVID vaccine will be approved in each of the jurisdictions. However, the U.S. Food and Drug Administration (FDA) …
Seven months ago, Nextbigfuture looked at the post pandemic world future as the pandemic was starting. We are now about halfway through the global pandemic. The World Bank’s baseline projection is for a 5.2% global economic contraction. China and several …
Moderna, Inc. (Nasdaq: MRNA) reported the results of its Phase 3 study of mRNA-1273 has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%. A secondary endpoint analyzed severe cases of COVID-19 …
Elon Musk is 49 so his risks are very low with COVID. Elon is a multi-billionaire and will be able to get the best treatments. Having two positive tests out of four then this is 99% likely that Elon has …
U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Eli Lilly & Companies investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results …
COVID-19 experts were expecting the first vaccines to only be 60% or 70% effective but phase III Pfizer and Biontech results show 90% effectiveness. Test subjects who received two injections of the vaccine three weeks apart had 90% fewer cases …
Pfizer and BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine. The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection …
The USA is likely heading towards European of daily COVID cases and if there is not stronger targeted mitigation this could get quite bad in the December-January timeframe according to Dr. Scott Gottlieb. The antibody drugs will not be able …
Three drugs out of 4000 existing drugs were identified as possibly effective against COVID. They are candidates for clinical trials. They are the antimalarial drug amodiaquine, the anti-psychotic zuclopenthixol, and the blood pressure medication nebivolol. University of New Mexico researcher …